Feature | March 07, 2014 | Melinda Taschetta-Millane

Joint Commission Calls for Use of Radiation Dose Monitoring

This industry has watched a trend in medical technology grow from a small ripple a couple of years ago into a potential tidal wave in 2014 due to growing concern over patient radiation dose levels from medical imaging. Use of radiation dose monitoring software came to the forefront when California, followed by Texas, created laws requiring medical facilities to record the amount of exposure patients receive from tests such as computed tomography (CT) and magnetic resonance imaging (MRI). 

Adoption of this software will be further accelerated by new Joint Commission standards released in December 2013, which starting in mid-2014 require the use of radiation dose monitoring software as part of its accreditation.

The Joint Commission’s (TJC) view is that it is not possible for a medical facility to know exactly how it is doing in regards to patient radiation safety or use of “as low and reasonably achievable” (ALARA) dosing principles if it does not track the data. The software enables hospitals to build a more robust radiation safety program and re-evaluate its radiation safety practices. Empirical data from these systems offer justification for changing imaging protocols and revision of workflows in both radiology exams and interventional procedures. 

In addition to requiring a method for collecting and storing patient dose data within the patient’s clinical record, TJC guidelines call for implementation of a powerful and dynamic radiation safety program with an engaged radiation safety committee and physicist who regulate radiation safety practices, annual performance evaluations of imaging equipment by a medical physicist, registration and certification of all radiology technologists, and updated protocols for all imaging procedures including pediatrics. There is a general feeling in radiology that it is only a matter of time before more states legislate the use of radiation dose monitoring software. There is also an expectation that dose level guidelines may eventually be set for all imaging protocols by the American College of Radiology (ACR), based on its national Dose Index Registry. 

Is your facilty prepared for compliance? I suspect radiation dose monitoring will be the topic of much ongoing conversation in 2014, and its software will be among the highlights on expo floors at upcoming radiology and radiation oncology conferences. To help you get a handle on radiation dose management, Imaging Technology News has created a new comparison chart that looks at different vendors that offer software solutions. (See page 8.) In addition, to gain some insight on dose recording, see “Recording and Managing Radiation Dose” on page 7 of this issue.

Related Content

Vinai Gondi, M.D., the Director of Research at the Northwestern Medicine Chicago Proton Center, Co-director of the Brain Tumor Center at Northwestern Medicine Cancer Center, Warrenville, and lead author of the NRG-BN001 abstract.

Vinai Gondi, M.D., director of research at the Northwestern Medicine Chicago Proton Center, co-director of the Brain Tumor Center at Northwestern Medicine Cancer Center, Warrenville, and lead author of the NRG-BN001 abstract.

News | Intensity Modulated Radiation Therapy (IMRT) | October 27, 2020
October 27, 2020 — A...
"Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4-15 brain metastases: A phase III randomized controlled trial" was presented by Jing Li, M.D., The University of Texas MD Anderson Cancer Center, at ASTRO20
News | Stereotactic Body Radiation Therapy (SBRT) | October 26, 2020
October 26, 2020 — Results of a new randomized phase III trial suggest that...
"Stereotactic ablative fractionated radiotherapy versus radiosurgery for oligometastatic neoplasia to the lung: A randomised phase II trial," presented by Shankar Siva, Ph.D., Peter MacCallum Cancer Centre, was presented at ASTRO20
News | Stereotactic Body Radiation Therapy (SBRT) | October 26, 2020
October 26, 2020 — A new study, conducted across 13 medical centers in Australia and New Zealand, strengthens the cas
"Initial report of a randomized trial comparing conventional- vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer" was presented by Ashesh Jani, M.D., Winship Cancer Institute of Emory University, at ASTRO20
News | PET Imaging | October 26, 2020
October 26, 2020 — Adding the advanced PET radiotracer...
A randomized phase II/III study comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractions versus 20Gy in 5 conventional palliative radiotherapy (CRT) fractions for patients with painful spinal metastases was presented by Arjun Sahgal, M.D., University of Toronto, today at ASTRO20
News | Radiation Therapy | October 26, 2020
October 26, 2020 — A new study shows using fewer and higher doses of high-precision...
Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions
News | Magnetic Resonance Imaging (MRI) | October 26, 2020
October 26, 2020 — ViewRay, Inc. announced that the company's MRIdian Linac MRI-guided radiation therapy system will
Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
October 25, 2020 — Treating lung cancer patients with prot...
Radiation Oncology Orchestrator (IntelliSpace Radiation Oncology) and Practice Management can reduce the time from patient referral to the start of treatment by up to half
News | Radiation Oncology | October 25, 2020
October 25, 2020 —Philips, a global leader in health technology, will showcase its latest advances in ...